/Investor DB

Serra Ventures — 2022 Investments

7 investments dated 2022 · listed companies and verified rows first · show all

Artio Medicalartiomedical.com𝕏Dec 2022

BiotechConsumerGamingMedia & EntertainmentPrairie Village, US

Frank Nicholas Franano(Executive Officer, Director)F. Nicholas Franano(Manager)Maria Sainz(Director)James M. Schultz(Director)Nathaniel Hagedorn(Director)John Ayres(Executive Officer)

CRISPR QCcrisprqc.cominMar 2022

CRISPR QC develops the CRISPR Analytics Platform, a graphene-based biosensor system that provides real-time quantitative kinetic measurements of RNP formation, DNA target binding, and CRISPR-Cas cleavage activity.

BiotechDeep TechHardwareSan Diego, US

Ross Bundy(Executive Officer, Director)inKiana Aran(Director)Michael Heltzen(Director)

BoardGeorge Bonaros(Director)Paul Grint(Director)Toby Richardson(Director)

Co-investorsBioBritSuncoast Ventures

Daasitydaasity.comin𝕏Jan 2022 · $15M

Daasity is an analytics and data platform for consumer brands that connects ecommerce, retail sales, marketing, and inventory data into a unified view without requiring data engineering.

Data & InfrastructureE-commerceRetail Tech

Co-investors1855 Capital PartnersCove FundOkapi Venture Capital

Kwantkwant.aiApr 2022

Kwant provides a construction workforce management platform that combines plug-and-play hardware sensors and AI software to track workers, automate safety and compliance reporting, and deliver real-time jobsite insights.

AI & Machine LearningConstruction TechSaaS

Eli Borton(Founder)Niran Shrestha(Founder)Timothy Axness(Founder)

Co-investorsForefront VentureInsurTechLiebenthal VenturesMetaPropMetaProp VenturesThe Pearl Fund+3 more

Network Perceptionnetwork-perception.cominMay 2022 · $13MAcquired

Network Perception offers NP-View, software that generates and maintains network maps to help organizations assess risk, verify network segmentation, and evaluate the security posture of their environments.

CybersecurityEnterprise SoftwareSaaSChicago, US

Robin Berthier(Chief Executive Officer, President, & Director)inTed Greene(Chief Operating Officer)inWilliam Sanders(Director)

BoardJeff Bocan(Director)Steve Westly(Director)inRobert Schultz(Director)in

Co-investorsEarly Light VenturesEarth FoundryEnergy FoundryEnergy Impact PartnersIllinois VenturesNotre Dame Founders Fund+3 more

NILnil-co.jpDec 2022 · $20M

NIL Co., Ltd. develops botanical-derived hair and scalp care products, including color treatments and scalp essences.

ConsumerDirect to ConsumerHealthtechNew MaterialsWellness & FitnessEbina, JP

Satokura Sato(Honorary Advisor (founder in 2015))佐藤正晃(Representative Director / CEO)Masaaki Sato(Representative Director, President & CEO)Hisashi Okada(Director & CTO)

Co-investorsFast Track InitiativeAdvantage Capital PartnersAlumni VenturesCourtside VenturesFlyover CapitalMyriad Ventures+3 more

VeriSIM Lifeverisimlife.comin𝕏Jan 2022

VeriSIM uses machine learning and computational simulation to accelerate drug development, replacing traditional trial-and-error experimentation with computational prediction to improve success rates and reduce animal testing.

AI & Machine LearningBiotechDigital HealthMedical DevicesSan Francisco, US

Jo Varshney(Founder & Chief Executive Officer)inDr. Vivek Gupta, Ph.D.(Scientific Co-Founder)

Co-investorsAmplify PartnersCerity Partners VenturesColorcon VenturesDeepwater Asset ManagementIntel CapitalLoup Ventures+8 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.